BRIEF-Ranbaxy to resume manufacture of generic Lipitor for U.S.
Feb 22 (Reuters) - Ranbaxy Laboratories Ltd : * Says resuming manufacture of generic lipitor for U.S.
- Ebola crisis turns a corner as U.S. issues new treatment protocols
- Total CEO de Margerie killed in Moscow business jet accident
- Obama makes rare campaign trail appearance, people leave early
- Apple's iPhone sales beat Street but iPad volumes slide
- U.S. Congress examining deal between NSA official, ex-agency chief